Northern Capital Management (Wisconsin)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-3,770
Closed -$349K 160
2018
Q2
$349K Sell
3,770
-325
-8% -$31.7K 0.08% 154
2018
Q1
$388K Sell
4,095
-90
-2% -$9.89K 0.1% 150
2017
Q4
$405K Sell
4,185
-70
-2% -$6.6K 0.1% 152
2017
Q3
$378K Sell
4,255
-25
-0.6% -$1.9K 0.12% 143
2017
Q2
$310K Hold
4,280
0.12% 139
2017
Q1
$279K Hold
4,280
0.11% 132
2016
Q4
$268K Sell
4,280
-15,550
-78% -$949K 0.11% 128
2016
Q3
$1.25M Buy
19,830
+1,905
+11% +$123K 0.56% 67
2016
Q2
$1.11M Sell
17,925
-75
-0.4% -$4.57K 0.5% 77
2016
Q1
$1.03M Buy
+18,000
New +$1M 0.46% 81
2015
Q1
Sell
-37,574
Closed -$2.46M 138
2014
Q4
$2.46M Sell
37,574
-327
-0.9% -$20.6K 1.21% 29
2014
Q3
$2.19M Sell
37,901
-14,840
-28% -$824K 1.11% 38
2014
Q2
$2.98M Sell
52,741
-10,390
-16% -$545K 1.48% 21
2014
Q1
$3.25M Buy
63,131
+6,460
+11% +$326K 1.62% 12
2013
Q4
$2.99M Sell
56,671
-4,160
-7% -$204K 1.56% 16
2013
Q3
$2.72M Buy
60,831
+3,366
+6% +$149K 1.59% 16
2013
Q2
$2.38M Buy
+57,465
New +$2.51M 1.48% 30

Other funds holding ABBV

Northern Capital Management (Wisconsin)'s ABBV Position: Q3 2018 in Review

Northern Capital Management (Wisconsin) sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 3,770 shares — an estimated $349K sold.

Northern Capital Management (Wisconsin) first reported a position in ABBV in Q2 2013 and held it in 17 quarters. The position peaked at $3.25M in Q1 2014. 1,957 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

  • Northern Capital Management (Wisconsin) reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
  • Northern Capital Management (Wisconsin) sold 3,770 AbbVie shares in Q3 2018, an estimated $349K.
  • Northern Capital Management (Wisconsin) first reported a position in AbbVie in Q2 2013 and held it in 17 quarters.
  • Northern Capital Management (Wisconsin)'s AbbVie position peaked at $3.25M in Q1 2014.
  • 1,957 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Northern Capital Management (Wisconsin)'s 13F filing for Q3 2018, filed 8 Nov 2018.